California Public Employees Retirement System lessened its position in Agilent Technologies, Inc. (NYSE:A) by 3.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 690,045 shares of the medical research company’s stock after selling 23,845 shares during the quarter. California Public Employees Retirement System owned about 0.23% of Agilent Technologies worth $101,996,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Twin Lakes Capital Management LLC purchased a new position in shares of Agilent Technologies in the first quarter valued at approximately $25,000. Eagle Bay Advisors LLC purchased a new position in Agilent Technologies during the second quarter worth approximately $26,000. Meridian Wealth Partners LLC purchased a new position in Agilent Technologies during the first quarter worth approximately $28,000. RMR Wealth Builders lifted its position in Agilent Technologies by 552.0% during the first quarter. RMR Wealth Builders now owns 326 shares of the medical research company’s stock worth $41,000 after buying an additional 276 shares in the last quarter. Finally, CoreFirst Bank & Trust purchased a new position in Agilent Technologies during the first quarter worth approximately $46,000.
A has been the subject of several recent analyst reports. Robert W. Baird raised their target price on Agilent Technologies from $144.00 to $170.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 18th. KeyCorp raised their target price on Agilent Technologies from $160.00 to $195.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 18th. Cowen raised their target price on Agilent Technologies from $165.00 to $200.00 and gave the stock an “outperform” rating in a research note on Friday, September 17th. They noted that the move was a valuation call. Societe Generale raised Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, June 22nd. Finally, SVB Leerink raised their target price on Agilent Technologies from $160.00 to $170.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 18th. One analyst has rated the stock with a hold rating and twenty-two have assigned a buy rating to the company. Based on data from MarketBeat, Agilent Technologies presently has a consensus rating of “Buy” and a consensus target price of $141.82.
NYSE:A opened at $150.22 on Thursday. The firm has a market cap of $45.48 billion, a PE ratio of 46.94, a price-to-earnings-growth ratio of 3.17 and a beta of 1.00. The stock has a fifty day moving average price of $165.93 and a 200 day moving average price of $148.87. Agilent Technologies, Inc. has a 12-month low of $100.65 and a 12-month high of $179.57. The company has a current ratio of 2.11, a quick ratio of 1.63 and a debt-to-equity ratio of 0.55.
Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Monday, August 16th. The medical research company reported $1.10 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.99 by $0.11. The company had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.54 billion. Agilent Technologies had a return on equity of 26.12% and a net margin of 16.12%. Agilent Technologies’s revenue for the quarter was up 25.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.78 EPS. Equities analysts forecast that Agilent Technologies, Inc. will post 4.31 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 27th. Stockholders of record on Tuesday, October 5th will be issued a $0.194 dividend. This represents a $0.78 annualized dividend and a dividend yield of 0.52%. The ex-dividend date of this dividend is Monday, October 4th. Agilent Technologies’s payout ratio is currently 23.78%.
Agilent Technologies Company Profile
Agilent Technologies, Inc engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets; Diagnostics and Genomics; and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that enable to identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level.
Read More: What is the Federal Reserve?
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.